Matching slides 96,741
Current window 88,441-88,470
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all

Component

88,441-88,470 of 96,741

filter-aware
23
The slide uses a three-column layout to explain the scientific basis and product profile.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
25
Includes a schematic of the SARS-CoV-2 genome and protein structure, alongside specific drug development strategies.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
26
The slide uses a three-pillar framework to summarize the drug's value proposition.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
04
The slide uses a patient persona (Crystal) to humanize the clinical goals of minimizing burden and restoring quality of life.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
05
argenx SE | Investor Presentation Deck | 26 slidesargenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Setup1 hit
14
The slide uses a split-screen layout: left side details the mechanism of action and current status of the MMN study, right side details the future roadmap.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
15
Includes a biological mechanism diagram on the left and a clinical trial roadmap on the right.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
17
The slide uses a hub-and-spoke style layout to represent partnerships, though it is not a formal framework.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
21
Clinical trial design slide showing a timeline of visits and dosing phases.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
22
The slide outlines a clinical trial protocol using a timeline-based process flow.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
23
Clinical trial design schematic showing 2:1 randomization between Efgartigimod and Placebo over 24 weeks.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
04
The slide uses a temple metaphor to represent strategic pillars.Azek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
18
Includes a highlight box indicating no debt maturities until 2025.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
19
The chart includes a callout box summarizing total debt, restricted vs. unrestricted amounts, and recent changes in restricted debt levels.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
21
The slide uses stacked bar charts to represent the split between B+L and BHC (excl. B+L) segments.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
05
The slide uses a comparison matrix to contrast 'Others' with 'Advantage' (Benson Hill) across five pillars, emphasizing a 6-10 year lead.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
The diagram uses a Venn-like structure to show the integration of three scientific disciplines into a central AI/ML operating system.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The slide uses a timeline-based progression (2023 -> Proof of Value -> Platform Innovation) mapped against product generations.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide uses a horizontal icon-based layout to represent the company's core assets, followed by a callout for strategic exploration.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses two distinct bar charts to illustrate market size and federal spending growth.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
06
The slide combines a list of value propositions with a testimonial box.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
13
The slide uses a visual progression arrow to imply growth.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
35
The slide uses a combination of a summary table for clinical endpoints and a dot plot for NHP toxicity data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
07
The slide uses a strong visual of the product to establish brand identity.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a problem-solution framing, identifying the 'why' (IL-6 is good) and the 'but' (it's unstable), leading to the company's value proposition at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
The slide highlights the clinical importance of IL-6 in various acute conditions.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
The slide details specific event counts and target hazard ratios for OS and PFS endpoints.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
25
Waterfall plot displays individual patient responses; PD indicates Progressive Disease threshold.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
39
The chart shows a clear dose-response/timing-response relationship where earlier treatment leads to lower viral titers.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
06
The slide uses a timeline-annotated line chart to correlate market events with price volatility.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit